Resmed Inc. diskutieren
Resmed Inc.
WKN: 895878 / Symbol: RMD / Name: ResMed / Aktie / Ausrüstung & Versorgung / Large Cap /
200,00 €
-1,86 %
Buy Resmed Inc.
ResMed Inc. (NYSE: RMD) is now covered by analysts at Mizuho. They set a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its price target lowered by analysts at Mizuho from $255.00 to $180.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its price target lowered by analysts at Bank of America Co. from $250.00 to $230.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $275.00 to $175.00. They now have an "outperform" rating on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $169.00 price target on the stock, down previously from $180.00.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its price target lowered by analysts at Mizuho from $180.00 to $160.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at JPMorgan Chase & Co. from $160.00 to $195.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Needham & Company LLC from $180.00 to $215.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Mizuho from $180.00 to $195.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Oppenheimer Holdings Inc. from $185.00 to $205.00. They now have an "outperform" rating on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) is now covered by analysts at KeyCorp. They set an "overweight" rating and a $227.00 price target on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its "buy" rating re-affirmed by analysts at Mizuho. They now have a $215.00 price target on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Needham & Company LLC from $215.00 to $224.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Needham & Company LLC from $224.00 to $236.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at KeyCorp from $227.00 to $238.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat
Neueste Beiträge
StockNews_com in TechnipFMC PLC diskutieren